In Reply We thank Wolde Sellasie et al for their careful reading of our study examining surgical approaches for sporadic medullary thyroid cancer. They raise important methodological considerations, including variation in the definition of surgical procedures, differences in baseline risk between groups, and uncertainty in the interpretation of biochemical outcomes. These concerns reflect limitations of systematic reviews, particularly the absence of individual patient–level information. In this reply, we clarify how these issues were handled in our study.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Further Methodological and Clinical Reflections | 0 | 8.13 | 01-08-2026 |
| 2 | Total Thyroidectomy vs Lobectomy for Sporadic Medullary Thyroid Cancer | 0 | 7.74 | 01-04-2026 |
| 3 | Serum and Tumor PD-L1 Expression and Aggressive Clinicopathologic Features in Papillary Thyroid Carcinoma | 0 | 12.37 | 13-08-2026 |
| 4 | Thermal Ablation for Papillary Thyroid Microcarcinoma | 0 | 6.4 | 01-04-2026 |
| 5 | Tumor Debulking Plus Chemotherapy for Multiorgan Metastatic Colorectal Cancer—Reply | 0 | 6.33 | 18-08-2026 |
| 6 | Artificial Intelligence–Based Risk Prediction Models for Complications After Tongue Cancer Surgery | 0 | 7.24 | 01-08-2026 |
| 7 | Caution in Interpreting Survival After for Salvage Focal Therapy vs Salvage Radical Prostatectomy | 0 | 6.4 | 01-07-2026 |
| 8 | Caution in Interpreting Survival After for Salvage Focal Therapy vs Salvage Radical Prostatectomy | 0 | 8.37 | 01-07-2026 |
| 9 | Efficacy of Indocyanine Green-guided Thyroidectomy in Preserving Parathyroid Glands: A Randomized Controlled Trial | 0 | 20.53 | 19-08-2026 |